These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Outcomes of a trial of HIV-1 immunogen in patients with HIV infection. Lurie P; Wolfe SM JAMA; 2001 May; 285(17):2193-5. PubMed ID: 11325316 [No Abstract] [Full Text] [Related]
23. Cellular immune responses in asymptomatic human immunodeficiency virus type 1 (HIV-1) infection and effects of vaccination with recombinant envelope glycoprotein of HIV-1. Gorse GJ; Simionescu RE; Patel GB Clin Vaccine Immunol; 2006 Jan; 13(1):26-32. PubMed ID: 16425996 [TBL] [Abstract][Full Text] [Related]
24. The design and testing of HIV prophylactic vaccines. Ada G AIDS Res Hum Retroviruses; 1992 May; 8(5):758-63. PubMed ID: 1515227 [No Abstract] [Full Text] [Related]
25. Effect of therapeutic immunization with HIV type 1 recombinant glycoprotein 160 ImmunoAG vaccine in HIV-infected individuals with CD4+ T cell counts of >or=500 and 200-400/mm3 (AIDS Clinical Trials Group Study 246/946). Kundu-Raychaudhuri S; Sevin A; Kilgo P; Nokta M; Pollard RB; Merigan TC AIDS Res Hum Retroviruses; 2001 Oct; 17(15):1371-8. PubMed ID: 11679149 [TBL] [Abstract][Full Text] [Related]
26. Web alert. Molecular, viral and cell-based vaccines for disease prevention and therapy. Stephens AC Curr Opin Mol Ther; 2004 Feb; 6(1):6-7. PubMed ID: 15011774 [No Abstract] [Full Text] [Related]
28. Assessment of gag DNA and genomic RNA in peripheral blood mononuclear cells in HIV-infected patients receiving intervention with a recombinant gp 160 subunit vaccine in a phase I study. Vahey M; Birx DL; Michael NL; Burke DS; Redfield RR AIDS Res Hum Retroviruses; 1994 Jun; 10(6):649-54. PubMed ID: 8074929 [No Abstract] [Full Text] [Related]
29. A therapeutic HIV vaccine using coxsackie-HIV recombinants: a possible new strategy. Halim SS; Collins DN; Ramsingh AI AIDS Res Hum Retroviruses; 2000 Oct; 16(15):1551-8. PubMed ID: 11054268 [TBL] [Abstract][Full Text] [Related]
30. AIDS vaccine: efficacy, safety and ethics. Veljkovic V; Veljkovic N; Glisic S; Ho MW Vaccine; 2008 Jun; 26(24):3072-7. PubMed ID: 18164521 [TBL] [Abstract][Full Text] [Related]
31. The use of Zairian children in HIV vaccine experimentation: a cross-cultural study in medical ethics. Nairn TA Annu Soc Christ Ethics; 1993; ():223-43. PubMed ID: 12568073 [No Abstract] [Full Text] [Related]
32. Update on HIV vaccines. Meldorf M; Corey L STEP Perspect; 1997; 9(2):5-6, 8-9. PubMed ID: 11364929 [TBL] [Abstract][Full Text] [Related]